These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34973034)

  • 1. A Multiscale Mathematical Model for Tumor Growth, Incorporating the GLUT1 Expression.
    Ampatzoglou P; Kariotou F; Hadjinicolaou M
    Adv Exp Med Biol; 2021; 1338():273-281. PubMed ID: 34973034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemical energy approach of avascular tumor growth: multiscale modeling and qualitative results.
    Ampatzoglou P; Dassios G; Hadjinicolaou M; Kourea HP; Vrahatis MN
    Springerplus; 2015; 4():660. PubMed ID: 26558163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of time delays on the dynamics of avascular tumor growth.
    Byrne HM
    Math Biosci; 1997 Sep; 144(2):83-117. PubMed ID: 9258002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
    Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
    J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARα Promotes Cancer Cell Glut1 Transcription Repression.
    You M; Jin J; Liu Q; Xu Q; Shi J; Hou Y
    J Cell Biochem; 2017 Jun; 118(6):1556-1562. PubMed ID: 27918085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model.
    Roy M; Finley SD
    PLoS Comput Biol; 2019 Jun; 15(6):e1007053. PubMed ID: 31185009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake.
    Chen J; Cao L; Li Z; Li Y
    Hum Cell; 2019 Apr; 32(2):193-201. PubMed ID: 30868406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
    Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
    Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multiscale Mathematical Model of Tumour Invasive Growth.
    Peng L; Trucu D; Lin P; Thompson A; Chaplain MA
    Bull Math Biol; 2017 Mar; 79(3):389-429. PubMed ID: 28210916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
    Jóźwiak P; Lipińska A
    Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
    Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
    Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression.
    Grabellus F; Worm K; Schmid KW; Sheu SY
    Thyroid; 2012 Apr; 22(4):377-82. PubMed ID: 22376167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress.
    Gonzalez-Menendez P; Hevia D; Alonso-Arias R; Alvarez-Artime A; Rodriguez-Garcia A; Kinet S; Gonzalez-Pola I; Taylor N; Mayo JC; Sainz RM
    Redox Biol; 2018 Jul; 17():112-127. PubMed ID: 29684818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.
    Ma J; Liu W; Guo H; Li S; Cao W; Du X; Lei S; Hou W; Xiong L; Yao L; Li N; Li Y
    Breast Cancer Res; 2014 Mar; 16(2):R27. PubMed ID: 24636131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells.
    Cortes P; Riser BL; Asano K; Rodríguez-Barbero A; Narins RG; Yee J
    Kidney Int; 1998 Dec; 54(6):1985-98. PubMed ID: 9853263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
    Buller CL; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F588-96. PubMed ID: 21613414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.
    Young CD; Lewis AS; Rudolph MC; Ruehle MD; Jackman MR; Yun UJ; Ilkun O; Pereira R; Abel ED; Anderson SM
    PLoS One; 2011; 6(8):e23205. PubMed ID: 21826239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.